Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00792129 · ClinicalTrials.gov registry record

MIS MiLIF Versus Open

A clinical trial of Chronic Low Back Pain and Leg Pain, sponsored by Zimmer Biomet.

Completed
Registry status
113
Enrollment target
9
Study locations

NCT00792129 is a study of Chronic Low Back Pain and Leg Pain that has completed, run by Zimmer Biomet. The registered enrollment target is 113 participants, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (81% lower). The trial reports 9 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00792129, a study of Chronic Low Back Pain and Leg Pain, has completed, sponsored by Zimmer Biomet.

COMPLETED
Registry status
113 participants
Enrollment target
9
Study locations

Study Summary

This study is being undertaken to compare the clinical outcomes of patients that have unilateral posterolateral lumbar interbody fusion using a traditional open approach versus the MiLIF procedure based on the MiCOR Precision Bone Allograft, specialized Atavi instrumentation, and minimally invasive visualization capabilities.

Interventions

  • DEVICE The Atavi System

Study Locations (9)

Florida

  • Advanced Orthopedic Center - Port Charlotte
  • Southeastern Spine Center - Sarasota
  • Kennedy-White Orthopedic - Sarasota

California

  • La Jolla Spine Institute - La Jolla
  • Sharp Rees-Stealy Medical Group - San Diego

Oregon

  • Oregon Brain & Spinal Institute - Portland
  • Williamette Neurosurgery - Salem

Texas

  • William Beaumont Army Medical Center - El Paso

Virginia

  • Naval Medical Center - Portsmouth

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2004-04
Est. Completion 2009-06

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT00792129

The ClinicalTrials.gov registry entry for NCT00792129 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (81% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which The Atavi System is the first listed.

NCT00792129 reports 9 study locations spanning 5 distinct geographic areas - top geographies include Florida, California, Oregon.

Frequently Asked Questions

What is clinical trial NCT00792129 about?

NCT00792129 is a clinical study titled "MIS MiLIF Versus Open". This study is being undertaken to compare the clinical outcomes of patients that have unilateral posterolateral lumbar interbody fusion using a traditional open approach versus the MiLIF procedure based on the MiCOR Precision Bone Allograft, specialized Atavi instrumentation, and minimally invasive ...

What is the current status of trial NCT00792129?

This trial is currently completed. The enrollment target is 113 participants. The study started on 2004-04. Estimated completion is 2009-06.

What conditions does trial NCT00792129 study?

This clinical trial studies the following conditions: Chronic Low Back Pain, Leg Pain.

What interventions are being tested in trial NCT00792129?

The interventions under investigation include: The Atavi System (DEVICE).

Who is sponsoring clinical trial NCT00792129?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00792129 being conducted?

This trial has 9 study locations across California, Florida, Oregon, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.